Search

everythinglearnresearchcommunity

for

Search:↓

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

High mTORC1 activity slows hair growth and causes it to lose color.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Antizyme slows skin tumor growth by reducing cell growth in mice.

MCP@G improves diabetic wound healing by reducing stress and promoting tissue repair.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Alpha-ketoglutaric acid may help treat aging and age-related diseases.

PPARs help regulate skin health and could be used to treat skin disorders.

aPKCλ is essential for hair follicle stem cell maintenance and wound healing.

The scalp fat tissue of men with hair loss shows changes in gene activity that may contribute to their condition.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Phytochrome A is crucial for normal metabolism and development in tomato seedlings under far-red light.

ATP-sensitive potassium channels are important for hair growth.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

PPARα agonists may help treat alopecia areata by reducing inflammation.

A protein complex called mTORC1 likely affects when hair growth starts in mice.

Lipin-1 is important for skin cell differentiation and skin barrier function.

Retinoic acid affects male and female muscle energy use and function differently.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

The article concludes that while we understand a lot about how melanocytes age and how this can prevent cancer, there are still unanswered questions about certain pathways and genes involved.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Adding a second method to PROTACs could improve cancer treatment.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.